Santagostino E - Search Results

1

Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII.

Hermans C, Mahlangu J, Booth J, Schütz H, Santagostino E, Young G, Lee HY, Steinitz-Trost KN, Blanchette V, Berntorp E. Hermans C, et al. Among authors: santagostino e. Haemophilia. 2018 May;24(3):376-384. doi: 10.1111/hae.13483. Epub 2018 May 6. Haemophilia. 2018. PMID: 29732708

2

Adverse effects of treatment with porcine factor VIII.

Gringeri A, Santagostino E, Tradati F, Giangrande PL, Mannucci PM. Gringeri A, et al. Among authors: santagostino e. Thromb Haemost. 1991 Mar 4;65(3):245-7. Thromb Haemost. 1991. PMID: 1904652

3

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.

Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, Bagnall R, Peake IR, Berntorp E, Mauser Bunschoten EP, Fijnvandraat K, Kasper CK, White G, Santagostino E. Hay CR, et al. Among authors: santagostino e. Thromb Haemost. 1998 Apr;79(4):762-6. Thromb Haemost. 1998. PMID: 9569189

4

Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience.

DiMichele DM, Gorman PO, Kasper CK, Mannucci PM, Santagostino E, Hay CR. DiMichele DM, et al. Among authors: santagostino e. Haemophilia. 2002 Jan;8 Suppl 1:9-12; discussion 28-32. doi: 10.1046/j.1365-2516.2002.00129.x. Haemophilia. 2002. PMID: 11882076

5

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII.

Gringeri A, Tagliaferri A, Tagariello G, Morfini M, Santagostino E, Mannucci P; ReFacto-AICE Study Group. Gringeri A, et al. Among authors: santagostino e. Br J Haematol. 2004 Aug;126(3):398-404. doi: 10.1111/j.1365-2141.2004.05058.x. Br J Haematol. 2004. PMID: 15257713 Free article. Clinical Trial.

6

Optimizing factor prophylaxis for the haemophilia population: where do we stand?

Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R. Blanchette VS, et al. Among authors: santagostino e. Haemophilia. 2004 Oct;10 Suppl 4:97-104. doi: 10.1111/j.1365-2516.2004.00998.x. Haemophilia. 2004. PMID: 15479380 Review.

7

Hepatitis C in haemophilia: lights and shadows.

Rumi MG, De Filippi F, Santagostino E, Colombo M. Rumi MG, et al. Among authors: santagostino e. Haemophilia. 2004 Oct;10 Suppl 4:211-5. doi: 10.1111/j.1365-2516.2004.00980.x. Haemophilia. 2004. PMID: 15479400 Review.

8

Managing the pediatric patient and the adolescent/adult transition.

Valentino LA, Santagostino E, Blanchette V, van den Berg M. Valentino LA, et al. Among authors: santagostino e. Semin Thromb Hemost. 2006 Jun;32 Suppl 2:28-31. doi: 10.1055/s-2006-946912. Semin Thromb Hemost. 2006. PMID: 16804833 Review.

9

Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.

Mannucci PM, Abshire T, Dimichele D, Santagostino E, Blanchette V. Mannucci PM, et al. Among authors: santagostino e. Haemophilia. 2006 Jul;12(4):429-34. doi: 10.1111/j.1365-2516.2006.01288.x. Haemophilia. 2006. PMID: 16834746 No abstract available.

10

Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).

Mannucci PM, Gringeri A, Peyvandi F, Santagostino E. Mannucci PM, et al. Among authors: santagostino e. Haemophilia. 2007 Dec;13 Suppl 5:65-8. doi: 10.1111/j.1365-2516.2007.01580.x. Haemophilia. 2007. PMID: 18078400 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters